Astrotech Corp

Aktienanalyse zu Astrotech Corp (ASTC)

$4.930

-0.256 (-5.19%)Zum Schluss

Loading chart…
Hoch
5.310
Eröffnung
5.310
Volumengewichteter Durchschnittskurs
4.96
Volumen
52.24K
Marktkap.
15.81M
Tief
4.650
Umsatz
259.27K
EV/EBITDA, TTM
0.00

Astrotech Corporation is a spectrometry company, commercializing the Astrotech Mass Spectrometer Technology platform (AMS Technology). The Company's business units include Astrotech Technologies, Inc., 1st Detect Corporation, AgLAB, Inc., BreathTech Corporation, Pro-Control, Inc., and EN-SCAN, Inc. Astrotech Technologies, Inc. owns and licenses the intellectual property related to AMS Technology. 1st Detect Corporation is a manufacturer of explosives trace detectors and narcotics trace detectors developed for use in security and detection at airports, cargo hubs, military bases, law enforcement centers, and others. AgLAB, Inc. develops a series of mass spectrometers for use in the hemp and cannabis market with initial focus on optimizing yields in the distillation processes. BreathTech Corporation is developing a breath analysis tool to screen for volatile organic compound metabolites. Pro-Control, Inc. is focused on applying AMS Technology in industrial process control applications.

KI-Analyse of Astrotech Corp (ASTC)

Verkaufen

Astrotech Corp is not a good buy right now due to its negative financial performance and high risk factors. The current price is $6.81, with an RSI of 38.64 indicating oversold conditions. However, the forward P/E ratio is 10.21, which suggests potential undervaluation, but the company has been burning cash at a rate of $14.9 million annually with only $1.05 million in revenue, leading to severe liquidity concerns.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Astrotech Corp (ASTC) beträgt 10.21, verglichen mit dem 5-Jahres-Durchschnitt von 1.36.

Erwartetes KGV

Stark überbewertet
5J-Durchschnitt P/E
1.36
Aktuelles P/E
10.21
Überbewertet
4.79
Unterbewertet
-2.07

Erwartetes EV/EBITDA

Stark unterbewertet
5J-Durchschnitt EV/EBITDA
0.00
Aktuelles EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes KUV

Unterbewertet
5J-Durchschnitt P/S
7.16
Aktuelles P/S
0.00
Überbewertet
10.77
Unterbewertet
3.54

Alphio-AI-Kursszenarien für ASTC

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%ASTC

$4.99

Szenariopreis

B

Basis

Basis · 50%ASTC

$4.92

Szenariopreis

B

Bärisch

Bärisch · 25%ASTC

$4.51

Szenariopreis

Event-Zeitleiste

2026-09-25 (ET)

16:30:00

Major Averages Rise as Oil Prices Retreat

13:00:00

Major Averages Rise as Oil Prices Retreat

08:30:00

Astrotech Reports FY26 Revenue of $913,000

2026-07-22 (ET)

09:00:00

Astrotech Expands Board to Six Directors

2026-06-30 (ET)

09:00:00

Astrotech Submits $20M Proposal to NASA

News

ASTC FAQ – beantwortet von Alphio AI

Astrotech Corporation is a spectrometry company, commercializing the Astrotech Mass Spectrometer Technology platform (AMS Technology). The Company's business units include Astrotech Technologies, Inc., 1st Detect Corporation, AgLAB, Inc., BreathTech Corporation, Pro-Control, Inc., and EN-SCAN, Inc. Astrotech Technologies, Inc. owns and licenses the intellectual property related to AMS Technology. 1st Detect Corporation is a manufacturer of explosives trace detectors and narcotics trace detectors developed for use in security and detection at airports, cargo hubs, military bases, law enforcement centers, and others. AgLAB, Inc. develops a series of mass spectrometers for use in the hemp and cannabis market with initial focus on optimizing yields in the distillation processes. BreathTech Corporation is developing a breath analysis tool to screen for volatile organic compound metabolites. Pro-Control, Inc. is focused on applying AMS Technology in industrial process control applications. It operates in the Technology sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

Astrotech Corp is not a good buy right now due to its negative financial performance and high risk factors. The current price is $6.81, with an RSI of 38.64 indicating oversold conditions. However, the forward P/E ratio is 10.21, which suggests potential undervaluation, but the company has been burning cash at a rate of $14.9 million annually with only $1.05 million in revenue, leading to severe liquidity concerns.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln